Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Tumor resistance to anticancer drugs is a significant challenge in chemotherapy.
• Multidrug resistance (MDR) often arises from the cellular efflux of drugs by ATP-binding cassette (ABC) transporters, including P-glycoprotein (P-gp).

Purpose of the Study:

• To identify novel compounds with selective cytotoxicity against multidrug-resistant (MDR) cancer cells.
• To explore the potential of naturally occurring aurones as a new class of anticancer agents targeting MDR tumors.

Main Methods:

• Screening of a chemolibrary containing 140 compounds to identify MDR-selective agents.
• Evaluating the cytotoxicity of identified compounds against P-gp-overexpressing MDR cells and sensitive parental cells.
• Investigating the mechanism of action using the P-gp inhibitor tariquidar.
• Designing and synthesizing azaaurone analogs based on structure-activity relationships.

Main Results:

• A set of naturally occurring aurones demonstrated enhanced cytotoxicity against P-gp-overexpressing MDR cells compared to sensitive cells.
• The MDR-selective toxicity of azaaurones was confirmed not to be mediated by P-gp.
• Structure-activity relationship studies guided the design of potent azaaurone analogs.

Conclusions:

• Naturally occurring aurones represent a promising scaffold for developing novel anticancer drugs.
• These compounds exhibit selective toxicity towards multidrug-resistant cancer cells, offering a potential strategy to overcome chemotherapy resistance.
• Further development of azaaurone analogs could lead to new therapeutic agents for MDR cancers.